| MolName | (5Z)-5-[[2-(3,4-dihydro-1H-isoquinolin-2-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(1,1-dioxothiolan-3-yl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C25H22N4O4S3 |
| Smiles | O=C(/C(/S1)=C/C2=C(N(CC3)Cc4c3cccc4)N=C(C=CC=C3)N3C2=O)N(C(CC2)CS2(=O)=O)C1=S |
| InChI | InChI=1S/C25H22N4O4S3/c30-23-19(13-20-24(31)29(25(34)35-20)18-9-12-36(32,33)15-18)22(26-21-7-3-4-10-28(21)23)27-11-8-16-5-1-2-6-17(16)14-27/h1-7,10,13,18H,8-9,11-12,14-15H2/t18-/m1/s1 |
| InChIK | FZIJJKBDLJWLMG-GOSISDBHSA-N |
| TotalMolweight | 538.672 |
| Molweight | 538.672 |
| MonoisotopicMass | 538.080316 |
| CLogP | 0.4089 |
| CLogS | -5.306 |
| H Acceptors | 8 |
| TotalSurfaceArea | 369.6 |
| Relative PSA | 0.33093 |
| PolarSurfaceArea | 156.13 |
| Druglikeness | 3.0168 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.44444 |
| Fragments | 1 |
| Non HAtoms | 36 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 3 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 10 |
| Symmetricatoms | 1 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-5-[[2-(3,4-dihydro-1H-isoquinolin-2-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(1,1-dioxothiolan-3-yl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[2-(3,4-dihydro-1H-isoquinolin-2-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(1,1-dioxothiolan-3-yl)-2-sulfanylidene-1,3-thiazolidin-4-one